Table 1 Demographics of the TRIAD, EMIF and iNPH cohorts. For more detailed information of the cohorts refer to the Supplementary material S2-S4. Amyloid and/or tau positivity were evaluated based on different biomarker modalities: PET in the case of TRIAD, CSF fluid biomarker measurements in the case of EMIF and cortical brain biopsy in the case of the iNPH cohort. Abbreviations: TRIAD, Translational Biomarkers in Aging and Dementia; PET, positron emission tomography; EMIF, European Medical Information Framework; iNPH, idiopathic normal pressure hydrocephalus; CU, cognitively unimpaired; SCI, subjective cognitive impairment; MCI, mild cognitive impairment; AD, Alzheimer’s disease
